Relay Therapeutics, Inc. (RLAY) Cash Flow Statement
Relay Therapeutics, Inc. (RLAY) generated -$212.2M of operating cash flow over the twelve months to 2026-06-30, spent $0 on capital expenditure and had free cash flow of -$212.2M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
RLAYRelay Therapeutics, Inc.Follow RLAY — free
—
Price chart with a free account
- Market cap
- 4.0B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -0.10 | -0.07 | -0.23 | -0.30 | -0.25 | -0.24 | -0.21 | |
| Capital expenditure | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | -0.00 | |
| Free cash flow | -0.10 | -0.08 | -0.24 | -0.30 | -0.25 | -0.24 | -0.21 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | |
| Stock-based compensation | 0.03 | 0.05 | 0.06 | 0.09 | 0.09 | 0.06 | — |
USD billions · SEC XBRL
Relay Therapeutics, Inc. — questions
- What is Relay Therapeutics, Inc.'s operating cash flow?
- -$212.2M over the twelve months to 2026-06-30.
- How much does Relay Therapeutics, Inc. spend on capital expenditure?
- $0 over the twelve months to 2026-06-30.
- What is Relay Therapeutics, Inc.'s free cash flow?
- -$212.2M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Relay Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.